Cargando…

Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study

BACKGROUND: Long-term outcome in multiple sclerosis (MS) depends on early treatment. In patients with acute optic neuritis (ON), an early inflammatory event, we investigated markers in cerebrospinal fluid (CSF), which may predict a diagnosis of MS. METHODS: Forty patients with acute ON were recruite...

Descripción completa

Detalles Bibliográficos
Autores principales: Olesen, M. N., Soelberg, K., Debrabant, B., Nilsson, A. C., Lillevang, S. T., Grauslund, J., Brandslund, I., Madsen, J. S., Paul, F., Smith, T. J., Jarius, S., Asgari, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410527/
https://www.ncbi.nlm.nih.gov/pubmed/30857557
http://dx.doi.org/10.1186/s12974-019-1440-5
_version_ 1783402262524067840
author Olesen, M. N.
Soelberg, K.
Debrabant, B.
Nilsson, A. C.
Lillevang, S. T.
Grauslund, J.
Brandslund, I.
Madsen, J. S.
Paul, F.
Smith, T. J.
Jarius, S.
Asgari, N.
author_facet Olesen, M. N.
Soelberg, K.
Debrabant, B.
Nilsson, A. C.
Lillevang, S. T.
Grauslund, J.
Brandslund, I.
Madsen, J. S.
Paul, F.
Smith, T. J.
Jarius, S.
Asgari, N.
author_sort Olesen, M. N.
collection PubMed
description BACKGROUND: Long-term outcome in multiple sclerosis (MS) depends on early treatment. In patients with acute optic neuritis (ON), an early inflammatory event, we investigated markers in cerebrospinal fluid (CSF), which may predict a diagnosis of MS. METHODS: Forty patients with acute ON were recruited in a prospective population-based cohort with median 29 months (range 19–41) of follow-up. Paired CSF and serum samples were taken within 14 days (range 2–38), prior to treatment. Prospectively, 16/40 patients were by a uniform algorithm diagnosed with MS (MS-ON) and 24 patients continued to manifest isolated ON (ION) during follow-up. Levels of cytokines and neurofilament light chain (NF-L) were measured at the onset of acute ON and compared to healthy controls (HC). Significance levels were corrected for multiple comparisons (“q”). The predictive value of biomarkers was determined with multivariable prediction models using nomograms. RESULTS: CSF TNF-α, IL-10, and CXCL13 levels were increased in MS-ON compared to those in ION patients (q = 0.021, 0.004, and 0.0006, respectively). MS-ON patients had increased CSF pleocytosis, IgG indices, and oligoclonal bands (OCBs) compared to ION (q = 0.0007, q = 0.0058, and q = 0.0021, respectively). CSF levels of IL-10, TNF-a, IL-17A, and CXCL13 in MS-ON patients correlated with leukocyte counts (r > 0.69 and p < 0.002) and IgG index (r > 0.55, p < 0.037). CSF NF-L levels were increased in ON patients compared to those in HC (q = 0.0077). In MS-ON, a progressive increase in NF-L levels was observed at 7 to 14 days after disease onset (r = 0.73, p < 0.0065). Receiver-operating characteristic (ROC) curves for two multivariable prediction models were generated, with IL-10, CXCL13, and NF-L in one (“candidate”) and IgG index, OCB, and leukocytes in another (“routine”). Area under the curve was 0.89 [95% CI 0.77–1] and 0.86 [0.74–0.98], respectively. Predictions of the risk of MS diagnosis were illustrated by two nomograms. CONCLUSIONS: CSF TNF-α, IL-10, CXCL13, and NF-L levels were associated with the development of MS, suggesting that the inflammatory and neurodegenerative processes occurred early. Based on subsequent diagnosis, we observed a high predictive value of routine and candidate biomarkers in CSF for the development of MS in acute ON. The nomogram predictions may be useful in the diagnostic work-up of MS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-019-1440-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6410527
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64105272019-03-21 Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study Olesen, M. N. Soelberg, K. Debrabant, B. Nilsson, A. C. Lillevang, S. T. Grauslund, J. Brandslund, I. Madsen, J. S. Paul, F. Smith, T. J. Jarius, S. Asgari, N. J Neuroinflammation Research BACKGROUND: Long-term outcome in multiple sclerosis (MS) depends on early treatment. In patients with acute optic neuritis (ON), an early inflammatory event, we investigated markers in cerebrospinal fluid (CSF), which may predict a diagnosis of MS. METHODS: Forty patients with acute ON were recruited in a prospective population-based cohort with median 29 months (range 19–41) of follow-up. Paired CSF and serum samples were taken within 14 days (range 2–38), prior to treatment. Prospectively, 16/40 patients were by a uniform algorithm diagnosed with MS (MS-ON) and 24 patients continued to manifest isolated ON (ION) during follow-up. Levels of cytokines and neurofilament light chain (NF-L) were measured at the onset of acute ON and compared to healthy controls (HC). Significance levels were corrected for multiple comparisons (“q”). The predictive value of biomarkers was determined with multivariable prediction models using nomograms. RESULTS: CSF TNF-α, IL-10, and CXCL13 levels were increased in MS-ON compared to those in ION patients (q = 0.021, 0.004, and 0.0006, respectively). MS-ON patients had increased CSF pleocytosis, IgG indices, and oligoclonal bands (OCBs) compared to ION (q = 0.0007, q = 0.0058, and q = 0.0021, respectively). CSF levels of IL-10, TNF-a, IL-17A, and CXCL13 in MS-ON patients correlated with leukocyte counts (r > 0.69 and p < 0.002) and IgG index (r > 0.55, p < 0.037). CSF NF-L levels were increased in ON patients compared to those in HC (q = 0.0077). In MS-ON, a progressive increase in NF-L levels was observed at 7 to 14 days after disease onset (r = 0.73, p < 0.0065). Receiver-operating characteristic (ROC) curves for two multivariable prediction models were generated, with IL-10, CXCL13, and NF-L in one (“candidate”) and IgG index, OCB, and leukocytes in another (“routine”). Area under the curve was 0.89 [95% CI 0.77–1] and 0.86 [0.74–0.98], respectively. Predictions of the risk of MS diagnosis were illustrated by two nomograms. CONCLUSIONS: CSF TNF-α, IL-10, CXCL13, and NF-L levels were associated with the development of MS, suggesting that the inflammatory and neurodegenerative processes occurred early. Based on subsequent diagnosis, we observed a high predictive value of routine and candidate biomarkers in CSF for the development of MS in acute ON. The nomogram predictions may be useful in the diagnostic work-up of MS. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-019-1440-5) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-11 /pmc/articles/PMC6410527/ /pubmed/30857557 http://dx.doi.org/10.1186/s12974-019-1440-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Olesen, M. N.
Soelberg, K.
Debrabant, B.
Nilsson, A. C.
Lillevang, S. T.
Grauslund, J.
Brandslund, I.
Madsen, J. S.
Paul, F.
Smith, T. J.
Jarius, S.
Asgari, N.
Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
title Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
title_full Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
title_fullStr Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
title_full_unstemmed Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
title_short Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
title_sort cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410527/
https://www.ncbi.nlm.nih.gov/pubmed/30857557
http://dx.doi.org/10.1186/s12974-019-1440-5
work_keys_str_mv AT olesenmn cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT soelbergk cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT debrabantb cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT nilssonac cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT lillevangst cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT grauslundj cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT brandslundi cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT madsenjs cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT paulf cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT smithtj cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT jariuss cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy
AT asgarin cerebrospinalfluidbiomarkersforpredictingdevelopmentofmultiplesclerosisinacuteopticneuritisapopulationbasedprospectivecohortstudy